Bessemer Group’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bessemer Group’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-30,942	Closed	-$292K	–	1660
2021 Q1	$292K	Buy	+30,942	New	+$426K	﹤0.01%	678
2020 Q3	–	Sell	-81,600	Closed	-$542K	–	1716
2020 Q2	$542K	Buy	+81,600	New	+$550K	﹤0.01%	944

Other funds holding GRTS

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bessemer Group's GRTS Position: Q2 2021 in Review

Bessemer Group sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2021, closing a stake of 30,942 shares — an estimated $292K sold.

Bessemer Group first reported a position in GRTS in Q2 2020 and held it in 2 quarters. The position peaked at $542K in Q2 2020. 102 funds tracked by Wall St. Rank hold GRTS as of Q2 2021.

Bessemer Group reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Bessemer Group sold 30,942 Gritstone bio, Inc. Common Stock shares in Q2 2021, an estimated $292K.
Bessemer Group first reported a position in Gritstone bio, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
Bessemer Group's Gritstone bio, Inc. Common Stock position peaked at $542K in Q2 2020.
102 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2021.

Based on Bessemer Group's 13F filing for Q2 2021, filed 6 Aug 2021.